Smart Pills Market by Application (Capsule Endoscopy, Drug Delivery, Patient Monitoring), Target Area (Esophagus, Small Intestine, Large Intestine, Stomach), End User (Hospitals, Diagnostic Centers), and Region - Global Forecast to 2030

1.1 Study Objectives
1.2 Market Definition
1.3 Study Scope
1.3.1 Market Segmentation & Geographical Spread
1.3.2 Inclusions & Exclusions
1.3.3 Years Considered
1.3.4 Currency Considered
1.4 Stakeholders
1.5 Summary of Changes

2.1 Research Data
2.1.1 Secondary Data
2.1.1.1 Key Sources of Secondary Data
2.1.1.2 Key Data from Secondary Sources
2.1.2 Primary Data
2.1.2.1 Objectives of Primary Research
2.1.2.2 Key Data from Primary Sources
2.1.2.3 Insights from Primary Experts
2.1.3 Market Size Estimation
2.1.3.1 Supply-Side Analysis
2.1.3.2 Bottom-Up Approach (Demand-Side Analysis)
2.1.3.3 Top-Down Approach (Parent Market Assessment)
2.2 Data Triangulation
2.3 Study Assumptions
2.4 Risk Analysis
2.5 Research Limitations
2.5.1 Methodology-Related Limitations
2.5.2 Scope-Related Limitations

4.1 Smart Pills Market Overview
4.2 North America: Smart Pills Market, by Application and Country, 2023
4.3 Smart Pills Market: Geographic Growth Opportunities
4.4 Smart Pills Market: Regional Mix
4.5 Smart Pills Market: Developed vs. Emerging Markets

5.1 Introduction
5.2 Market Dynamics
5.2.1 Drivers
5.2.1.1 Rising Demand for Non-Invasive Diagnostic Monitoring Devices
5.2.1.2 Technological Advancements in Capsule Endoscopy
5.2.1.3 Increasing Incidence of Colon Cancer
5.2.2 Restraints
5.2.2.1 High R&D Costs for Technological Developments and Advancements
5.2.2.2 Low Accuracy and Reliability of Sensors and Cameras in Smart Pills
5.2.3 Opportunities
5.2.3.1 Innovations in Sensor Technologies and Wireless Communication
5.2.3.2 Rising Need for Rapid Drug Delivery and Development
5.2.4 Challenges
5.2.4.1 Increased Patient Privacy and Data Security Concerns
5.2.4.2 Shortage of Skilled Healthcare Professionals
5.3 Industry Trends
5.3.1 Advancements in Sensor Technologies
5.3.2 Integration with AI and ML
5.3.3 Integration with Wearable Devices
5.4 Technology Analysis
5.4.1 Key Technologies
5.4.1.1 Wireless Communication Systems
5.4.1.2 Sensor Technologies
5.4.1.3 Self-Powered Ingestible Smart Pills
5.4.1.4 Adaptive Frame Rate Technologies
5.4.1.5 Imag
5.4.1.6 AI and ML
5.4.2 Complementary Technologies
5.4.2.1 Robotic Technologies
5.4.2.2 Data Analytics
5.4.3 Adjacent Technologies
5.4.3.1 IoT
5.4.3.2 Cloud Computing
5.5 Trends/Disruptions Impacting Customer's Business
5.6 Pipeline Analysis
5.7 Porter's Five Forces Analysis
5.7.1 Intensity of Competitive Rivalry
5.7.2 Threat of New Entrants
5.7.3 Threat of Substitutes
5.7.4 Bargaining Power of Suppliers
5.7.5 Bargaining Power of Buyers
5.8 Key Stakeholders & Buying Criteria
5.8.1 Key Stakeholders in Buying Process
5.8.2 Key Buying Criteria
5.9 Ecosystem Analysis
5.10 Value Chain Analysis
5.11 Tariff & Regulatory Analysis
5.11.1 Tariff Data Analysis
5.11.2 Regulatory Bodies, Government Agencies, and Other Organizations
5.11.3 Regulatory Landscape
5.11.3.1 North America
5.11.3.1.1 US
5.11.3.2 Europe
5.11.3.3 Asia-Pacific
5.11.3.3.1 Japan
5.11.3.3.2 China
5.11.3.3.3 India
5.12 Pricing Analysis
5.12.1 Average Selling Price of Smart Pills, by Key Player, 2023
5.12.2 Average Selling Price Trend for Capsule Endoscopes, by Region, 2020-2023
5.13 Case Study Analysis
5.13.1 Increased Imaging Capabilities for Patients with Small Bowel Abnormalities
5.13.2 Detection of Gastric Polyp & Erythema Through Magnetically Controlled Capsule Endoscopes
5.13.3 AI-Assisted Capsule Endoscopy to Detect Obscure Gastrointestinal Bleeding in High-Risk Cardiac Patients
5.14 Patent Analysis
5.14.1 Patent Publication Trends for Smart Pills
5.14.2 Insights: Jurisdiction and Top Applicant Analysis
5.14.3 List of Key Patents
5.15 Key Conferences & Events, 2025-2026
5.16 Unmet Needs & End-user Expectations
5.16.1 Unmet Needs
5.16.2 End-user Expectations
5.17 Trade Analysis
5.18 Investment & Funding Scenario
5.19 Business Model Analysis
5.19.1 Direct Sales to Healthcare Providers
5.19.2 Subscription-based Software and Data Analytics Services
5.20 Impact of AI/Gen AI on Smart Pills Market
5.20.1 Key Use Cases
5.20.2 Case Studies of AI/Gen AI Implementation
5.20.2.1 Capsocam Sv-1 Versus Pillcam Sb3 to Detect Obscure Gastrointestinal Bleeding
5.20.2.2 Aardex Group Partnered with Etectrx, Inc. to Track Medication-Taking Behaviors
5.20.3 Impact of AI/Gen AI on Interconnected and Adjacent Ecosystems
5.20.3.1 AI in Endoscopy
5.20.3.2 Wearable Devices
5.20.3.3 Digital Healthcare
5.20.3.4 Home Healthcare
5.20.4 User Readiness & Impact Assessment
5.20.4.1 User Readiness
5.20.4.1.1 User A: Hospitals
5.20.4.1.2 User B: Diagnostic Centers
5.20.4.2 Impact Assessment
5.20.4.2.1 User A: Hospitals
5.20.4.2.1.1 Implementation
5.20.4.2.1.2 Impact
5.20.4.2.2 User B: Diagnostic Centers
5.20.4.2.2.1 Implementation
5.20.4.2.2.2 Impact

6.1 Introduction
6.2 Small Intestine
6.2.1 Complexities in Diagnosis and Monitoring of Small Intestine to Aid Adoption of Smart Pills
6.3 Large Intestine
6.3.1 Increasing Incidence of Colorectal Cancer to Support Market Growth
6.4 Esophagus
6.4.1 High Prevalence of Gastroesophageal Reflux Disease and Barrett's Esophagus to Augment Market Growth
6.5 Stomach
6.5.1 Improved Diagnostic Accuracy and Effective Proximal Examination Scope of Gastric Diseases to Drive Market

7.1 Introduction
7.2 Capsule Endoscopy
7.2.1 Increased Ability to Assess Gastrointestinal Bleeding and Small Bowel Tumors to Drive Market
7.3 Patient Monitoring
7.3.1 Need for Streamlined Integration of Innovative Sensor Technologies to Drive Market
7.4 Targeted Drug Delivery
7.4.1 Site-Specific Drug Delivery to Minimize Drug Dosage and Reduce Healthcare Costs

8.1 Introduction
8.2 Occult Gastrointestinal Bleeding
8.2.1 Improved Diagnostic Accuracy to Fuel Uptake of Smart Pills as Patient-Friendly Alternative
8.3 Crohn's Disease
8.3.1 Technological Advancements in Capsule Endoscopy to Boost Adoption of Smart Pills
8.4 Celiac Disease
8.4.1 Rising Incidence of Small Intestine Disorders to Drive Market
8.5 Small Bowel Tumors
8.5.1 Growing Demand for Non-Invasive Diagnostics to Propel Market Growth
8.6 Other Disease Indications

9.1 Introduction
9.2 Hospitals
9.2.1 Increasing Prevalence of Inflammatory Bowel Disease to Boost Adoption of Smart Pills in Hospitals
9.3 Diagnostic Centers
9.3.1 Better Patient Experience and Improved Operational Efficiency to Boost Market Growth
9.4 Outpatient Settings
9.4.1 Need for Accessible and Cost-Effective Care to Spur Market Growth
9.5 Other End-users

10.1 Introduction
10.2 North America
10.2.1 Macroeconomic Outlook for North America
10.2.2 US
10.2.2.1 US to Dominate North American Smart Pills Market During Study Period
10.2.3 Canada
10.2.3.1 Rising Incidence of Ibd Among Geriatric Population to Propel Market Growth
10.3 Europe
10.3.1 Macroeconomic Outlook for Europe
10.3.2 Germany
10.3.2.1 Rising Prevalence of Crohn's Disease to Aid Market Growth
10.3.3 UK
10.3.3.1 Increasing Prevalence of Bowel Cancer and Colitis to Augment Market Growth
10.3.4 France
10.3.4.1 Favorable Reimbursement Coverage by Government and Third-Party Payers to Aid Market Growth
10.3.5 Italy
10.3.5.1 Growing Adoption of Capsule Endoscopy for Gastrointestinal Diseases to Propel Market Growth
10.3.6 Spain
10.3.6.1 Rising Demand for Non-Invasive Diagnostics to Fuel Uptake of Smart Pills
10.3.7 Rest of Europe
10.4 Asia-Pacific
10.4.1 Macroeconomic Outlook for Asia-Pacific
10.4.2 Japan
10.4.2.1 Increased Prevalence of Stomach Cancer and Favorable Reimbursement Scenario for Capsule Endoscopy to Drive Market
10.4.3 China
10.4.3.1 Increasing Geriatric Population and Rising Incidence of Gastric Cancer to Boost Market Growth
10.4.4 India
10.4.4.1 Rising Incidence of Ibd and Growing Adoption of Capsule Endoscopy to Support Market Growth
10.4.5 Rest of Asia-Pacific
10.5 Latin America
10.5.1 Macroeconomic Outlook for Latin America
10.5.2 Brazil
10.5.2.1 Favorable Government Policies and Presence of Universal Health Coverage to Aid Market Growth
10.5.3 Mexico
10.5.3.1 Increased Cancer Awareness and Favorable Government Initiatives to Drive Market
10.5.4 Rest of Latin America
10.6 Middle East & Africa
10.6.1 Macroeconomic Outlook for Middle East & Africa
10.6.2 GCC Countries
10.6.2.1 Increased Focus on Healthcare Infrastructure Development and High R&D Investment to Support Market Growth
10.6.3 Rest of Middle East & Africa

11.1 Introduction
11.2 Key Player Strategies/Right to Win
11.2.1 Overview of Strategies Adopted by Key Players in Smart Pills Market
11.3 Revenue Analysis, 2019-2023
11.4 Market Share Analysis, 2023
11.5 Company Evaluation Matrix: Key Players, 2023
11.5.1 Stars
11.5.2 Emerging Leaders
11.5.3 Pervasive Players
11.5.4 Participants
11.5.5 Company Footprint: Key Players, 2023
11.5.5.1 Company Footprint
11.5.5.2 Region Footprint
11.5.5.3 Application Footprint
11.5.5.4 Target Area Footprint
11.5.5.5 Disease Indication Footprint
11.5.5.6 End-user Footprint
11.5.5.7 Region Footprint
11.6 Company Evaluation Matrix: Startups/SMEs, 2023
11.6.1 Progressive Companies
11.6.2 Responsive Companies
11.6.3 Dynamic Companies
11.6.4 Starting Blocks
11.6.5 Competitive Benchmarking: Startups/SMEs, 2023
11.6.5.1 Detailed List of Key Startups/SME Players
11.6.5.2 Competitive Benchmarking of Key Startups/SME Players
11.7 Company Valuation & Financial Metrics
11.7.1 Financial Metrics
11.7.2 Company Valuation
11.8 Brand/Product Comparison
11.9 Competitive Scenario
11.9.1 Product Launches, Approvals, and Enhancements
11.9.2 Deals
11.9.3 Other Developments

12.1 Key Players
12.1.1 Medtronic
12.1.1.1 Business Overview
12.1.1.2 Products/Services/Solutions Offered
12.1.1.3 Recent Developments
12.1.1.3.1 Product Approvals & Enhancements
12.1.1.3.2 Deals
12.1.1.4 Analyst's View
12.1.1.4.1 Right to Win
12.1.1.4.2 Strategic Choices
12.1.1.4.3 Weaknesses & Competitive Threats
12.1.2 Olympus Corporation
12.1.2.1 Business Overview
12.1.2.2 Products/Services/Solutions Offered
12.1.2.3 Recent Developments
12.1.2.3.1 Other Developments
12.1.2.4 Analyst's View
12.1.2.4.1 Right to Win
12.1.2.4.2 Strategic Choices
12.1.2.4.3 Weaknesses & Competitive Threats
12.1.3 Capsovision, Inc.
12.1.3.1 Business Overview
12.1.3.2 Products/Services/Solutions Offered
12.1.3.3 Recent Developments
12.1.3.3.1 Product Approvals & Enhancements
12.1.3.4 Analyst's View
12.1.3.4.1 Right to Win
12.1.3.4.2 Strategic Choices
12.1.3.4.3 Weaknesses & Competitive Threats
12.1.4 Intromedic
12.1.4.1 Business Overview
12.1.4.2 Products/Services/Solutions Offered
12.1.4.3 Analyst's View
12.1.4.3.1 Right to Win
12.1.4.3.2 Strategic Choices
12.1.4.3.3 Weaknesses & Competitive Threats
12.1.5 Jinshan Science & Technology
12.1.5.1 Business Overview
12.1.5.2 Products/Services/Solutions Offered
12.1.5.3 Analyst's View
12.1.5.3.1 Right to Win
12.1.5.3.2 Strategic Choices
12.1.5.3.3 Weaknesses & Competitive Threats
12.1.6 Anx Robotics
12.1.6.1 Business Overview
12.1.6.2 Products/Services/Solutions Offered
12.1.6.3 Recent Developments
12.1.6.3.1 Product Launches, Approvals, and Enhancements
12.1.7 Shenzhen Jifu Medical Technology Co. Ltd.
12.1.7.1 Business Overview
12.1.7.2 Products/Services/Solutions Offered
12.1.8 Etectrx
12.1.8.1 Business Overview
12.1.8.2 Products/Services/Solutions Offered
12.1.8.3 Recent Developments
12.1.8.3.1 Product Enhancements
12.1.8.3.2 Deals
12.1.9 Bodycap
12.1.9.1 Business Overview
12.1.9.2 Products/Services/Solutions Offered
12.1.9.3 Recent Developments
12.1.9.3.1 Product Launches
12.1.9.3.2 Deals
12.1.10 Check-Cap
12.1.10.1 Business Overview
12.1.10.2 Products/Services/Solutions Offered
12.1.10.3 Recent Developments
12.1.10.3.1 Product Approvals
12.1.10.3.2 Expansions
12.1.11 Shangxian Minimal Invasive Inc.
12.1.11.1 Business Overview
12.1.11.2 Products/Services/Solutions Offered
12.2 Other Players
12.2.1 Veloce Corporation
12.2.2 Biocam
12.2.3 Endiatx
12.2.4 Rf Co. Ltd.
12.2.5 Celero Systems
12.2.6 Biora Therapeutics, Inc.
12.2.7 Innurvation
12.2.8 Rani Therapeutics
12.2.9 Motilis Medica SA

13.1 Discussion Guide
13.2 Knowledgestore: The Subscription Portal
13.3 Customization Options

Table 1 Smart Pills Market: Inclusions & Exclusions
Table 2 Smart Pills Market: Study Assumptions
Table 3 Smart Pills Market: Risk Analysis
Table 4 Smart Pills Market: Impact Analysis
Table 5 Sensor and Battery Types for Capsule Endoscopy Products
Table 6 Sensors Used for Vital Sign Monitoring Products
Table 7 Smart Pills Market: Drugs Under Pipeline
Table 8 Smart Pills Market: Porter's Five Forces Analysis
Table 9 Influence of Key Stakeholders on Buying Process, by Application (%)
Table 10 Key Buying Criteria for Smart Pills, by Application
Table 11 Tariff Data for HS Code 901890
Table 12 North America: Regulatory Bodies, Government Agencies, and Other Organizations
Table 13 Europe: Regulatory Bodies, Government Agencies, and Other Organizations
Table 14 Asia-Pacific: Regulatory Bodies, Government Agencies, and Other Organizations
Table 15 US Fda: Medical Device Classification
Table 16 US: Medical Device Regulatory Approval Process
Table 17 Europe: Level of Risk, Time, Cost, and Complexity of Registration Process
Table 18 Japan: Medical Devices Classification Under Pmda
Table 19 China: Classification Under Class I/II/III Medical Devices
Table 20 India: Level of Risk, Time, Cost, and Complexity of Registration Process
Table 21 Average Selling Price of Capsule Endoscopes, by Key Player, 2023 (USD)
Table 22 Average Selling Price Trend of Capsule Endoscopes, by Region, 2020-2023 (USD Per Unit)
Table 23 Case Study 1: Increased Imaging Capabilities for Patients with Small Bowel Abnormalities
Table 24 Case Study 2: Detection of Gastric Polyp & Erythema Through Magnetically Controlled Capsule Endoscopes
Table 25 Case Study 3: AI-Assisted Capsule Endoscopy to Detect Obscure Gastrointestinal Bleeding in High-Risk Cardiac Patients
Table 26 Smart Pills Market: List of Key Patents, January 2020-December 2024
Table 27 Smart Pills Market: List of Key Conferences & Events, January 2025-December 2026
Table 28 Smart Pills Market: Unmet Needs
Table 29 Smart Pills Market: End-user Expectations
Table 30 Top 10 Importers for Hsn Code 901890, by Country, 2020-2023 (USD Thousand)
Table 31 Top 10 Exporters for Hsn Code 901890, by Country, 2020-2023 (USD Thousand)
Table 32 Case Study 1: Capsocam Sv-1 Versus Pillcam Sb3 to Detect Obscure Gastrointestinal Bleeding
Table 33 Case Study 2: Aardex Group Partnered with Etectrx, Inc. to Track Medication-Taking Behaviors
Table 34 Smart Pills Market, by Target Area, 2022-2030 (USD Million)
Table 35 Smart Pills Market for Small Intestine, by Region, 2022-2030 (USD Million)
Table 36 Smart Pills Market for Large Intestine, by Region, 2022-2030 (USD Million)
Table 37 Smart Pills Market for Esophagus, by Region, 2022-2030 (USD Million)
Table 38 Smart Pills Market for Stomach, by Region, 2022-2030 (USD Million)
Table 39 Smart Pills Market, by Application, 2022-2030 (USD Million)
Table 40 Key Capsule Endoscopes Offered by Major Market Players
Table 41 Smart Pills Market for Capsule Endoscopy, by Region, 2022-2030 (USD Million)
Table 42 Key Patient Monitoring Smart Pills Offered by Major Market Players
Table 43 Smart Pills Market for Patient Monitoring, by Region, 2022-2030 (USD Million)
Table 44 Key Targeted Drug Delivery Smart Pills Under Pipeline
Table 45 Smart Pills Market for Targeted Drug Delivery, by Region, 2022-2030 (USD Million)
Table 46 Smart Pills Market, by Disease Indication, 2022-2030 (USD Million)
Table 47 Smart Pills Market for Occult Gastrointestinal Bleeding, by Region, 2022-2030 (USD Million)
Table 48 Smart Pills Market for Crohn's Disease, by Region, 2022-2030 (USD Million)
Table 49 Smart Pills Market for Celiac Disease, by Region, 2022-2030 (USD Million)
Table 50 Smart Pills Market for Small Bowel Tumors, by Region, 2022-2030 (USD Million)
Table 51 Smart Pills Market for Other Disease Indications, by Region, 2022-2030 (USD Million)
Table 52 Smart Pills Market, by End-user, 2022-2030 (USD Million)
Table 53 Smart Pills Market for Hospitals, by Region, 2022-2030 (USD Million)
Table 54 Smart Pills Market for Diagnostic Centers, by Region, 2022-2030 (USD Million)
Table 55 Smart Pills Market for Outpatient Settings, by Region, 2022-2030 (USD Million)
Table 56 Smart Pills Market for Other End-users, by Region, 2022-2030 (USD Million)
Table 57 Smart Pills Market, by Region, 2022-2030 (USD Million)
Table 58 Smart Pills Market for Capsule Endoscopy, by Region, 2022-2030 (Thousand Units)
Table 59 Smart Pills Market for Patient Monitoring, by Region, 2022-2030 (Thousand Units)
Table 60 North America: Smart Pills Market, by Country, 2022-2030 (USD Million)
Table 61 North America: Smart Pills Market, by Target Area, 2022-2030 (USD Million)
Table 62 North America: Smart Pills Market, by Application, 2022-2030 (USD Million)
Table 63 North America: Smart Pills Market, by Disease Indication, 2022-2030 (USD Million)
Table 64 North America: Smart Pills Market, by End-user, 2022-2030 (USD Million)
Table 65 US: Key Macroindicators
Table 66 US: Smart Pills Market, by Target Area, 2022-2030 (USD Million)
Table 67 US: Smart Pills Market, by Application, 2022-2030 (USD Million)
Table 68 US: Smart Pills Market, by Disease Indication, 2022-2030 (USD Million)
Table 69 US: Smart Pills Market, by End-user, 2022-2030 (USD Million)
Table 70 Canada: Key Macroindicators
Table 71 Canada: Smart Pills Market, by Target Area, 2022-2030 (USD Million)
Table 72 Canada: Smart Pills Market, by Application, 2022-2030 (USD Million)
Table 73 Canada: Smart Pills Market, by Disease Indication, 2022-2030 (USD Million)
Table 74 Canada: Smart Pills Market, by End-user, 2022-2030 (USD Million)
Table 75 Europe: Smart Pills Market, by Country, 2022-2030 (USD Million)
Table 76 Europe: Smart Pills Market, by Target Area, 2022-2030 (USD Million)
Table 77 Europe: Smart Pills Market, by Application, 2022-2030 (USD Million)
Table 78 Europe: Smart Pills Market, by Disease Indication, 2022-2030 (USD Million)
Table 79 Europe: Smart Pills Market, by End-user, 2022-2030 (USD Million)
Table 80 Germany: Key Macroindicators
Table 81 Germany: Smart Pills Market, by Target Area, 2022-2030 (USD Million)
Table 82 Germany: Smart Pills Market, by Application, 2022-2030 (USD Million)
Table 83 Germany: Smart Pills Market, by Disease Indication, 2022-2030 (USD Million)
Table 84 Germany: Smart Pills Market, by End-user, 2022-2030 (USD Million)
Table 85 UK: Key Macroindicators
Table 86 UK: Smart Pills Market, by Target Area, 2022-2030 (USD Million)
Table 87 UK: Smart Pills Market, by Application, 2022-2030 (USD Million)
Table 88 UK: Smart Pills Market, by Disease Indication, 2022-2030 (USD Million)
Table 89 UK: Smart Pills Market, by End-user, 2022-2030 (USD Million)
Table 90 France: Key Macroindicators
Table 91 France: Smart Pills Market, by Target Area, 2022-2030 (USD Million)
Table 92 France: Smart Pills Market, by Application, 2022-2030 (USD Million)
Table 93 France: Smart Pills Market, by Disease Indication, 2022-2030 (USD Million)
Table 94 France: Smart Pills Market, by End-user, 2022-2030 (USD Million)
Table 95 Italy: Key Macroindicators
Table 96 Italy: Smart Pills Market, by Target Area, 2022-2030 (USD Million)
Table 97 Italy: Smart Pills Market, by Application, 2022-2030 (USD Million)
Table 98 Italy: Smart Pills Market, by Disease Indication, 2022-2030 (USD Million)
Table 99 Italy: Smart Pills Market, by End-user, 2022-2030 (USD Million)
Table 100 Spain: Key Macroindicators
Table 101 Spain: Smart Pills Market, by Target Area, 2022-2030 (USD Million)
Table 102 Spain: Smart Pills Market, by Application, 2022-2030 (USD Million)
Table 103 Spain: Smart Pills Market, by Disease Indication, 2022-2030 (USD Million)
Table 104 Spain: Smart Pills Market, by End-user, 2022-2030 (USD Million)
Table 105 Rest of Europe: Smart Pills Market, by Target Area, 2022-2030 (USD Million)
Table 106 Rest of Europe: Smart Pills Market, by Application, 2022-2030 (USD Million)
Table 107 Rest of Europe: Smart Pills Market, by Disease Indication, 2022-2030 (USD Million)
Table 108 Rest of Europe: Smart Pills Market, by End-user, 2022-2030 (USD Million)
Table 109 Asia-Pacific: Smart Pills Market, by Country, 2022-2030 (USD Million)
Table 110 Asia-Pacific: Smart Pills Market, by Target Area, 2022-2030 (USD Million)
Table 111 Asia-Pacific: Smart Pills Market, by Application, 2022-2030 (USD Million)
Table 112 Asia-Pacific: Smart Pills Market, by Disease Indication, 2022-2030 (USD Million)
Table 113 Asia-Pacific: Smart Pills Market, by End-user, 2022-2030 (USD Million)
Table 114 Japan: Key Macroindicators
Table 115 Japan: Smart Pills Market, by Target Area, 2022-2030 (USD Million)
Table 116 Japan: Smart Pills Market, by Application, 2022-2030 (USD Million)
Table 117 Japan: Smart Pills Market, by Disease Indication, 2022-2030 (USD Million)
Table 118 Japan: Smart Pills Market, by End-user, 2022-2030 (USD Million)
Table 119 China: Key Macroindicators
Table 120 China: Smart Pills Market, by Target Area, 2022-2030 (USD Million)
Table 121 China: Smart Pills Market, by Application, 2022-2030 (USD Million)
Table 122 China: Smart Pills Market, by Disease Indication, 2022-2030 (USD Million)
Table 123 China: Smart Pills Market, by End-user, 2022-2030 (USD Million)
Table 124 India: Key Macroindicators
Table 125 India: Smart Pills Market, by Target Area, 2022-2030 (USD Million)
Table 126 India: Smart Pills Market, by Application, 2022-2030 (USD Million)
Table 127 India: Smart Pills Market, by Disease Indication, 2022-2030 (USD Million)
Table 128 India: Smart Pills Market, by End-user, 2022-2030 (USD Million)
Table 129 Rest of Asia-Pacific: Smart Pills Market, by Target Area, 2022-2030 (USD Million)
Table 130 Rest of Asia-Pacific: Smart Pills Market, by Application, 2022-2030 (USD Million)
Table 131 Rest of Asia-Pacific: Smart Pills Market, by Disease Indication, 2022-2030 (USD Million)
Table 132 Rest of Asia-Pacific: Smart Pills Market, by End-user, 2022-2030 (USD Million)
Table 133 Latin America: Smart Pills Market, by Country, 2022-2030 (USD Million)
Table 134 Latin America: Smart Pills Market, by Target Area, 2022-2030 (USD Million)
Table 135 Latin America: Smart Pills Market, by Application, 2022-2030 (USD Million)
Table 136 Latin America: Smart Pills Market, by Disease Indication, 2022-2030 (USD Million)
Table 137 Latin America: Smart Pills Market, by End-user, 2022-2030 (USD Million)
Table 138 Brazil: Key Macroindicators
Table 139 Brazil: Smart Pills Market, by Target Area, 2022-2030 (USD Million)
Table 140 Brazil: Smart Pills Market, by Application, 2022-2030 (USD Million)
Table 141 Brazil: Smart Pills Market, by Disease Indication, 2022-2030 (USD Million)
Table 142 Brazil: Smart Pills Market, by End-user, 2022-2030 (USD Million)
Table 143 Mexico: Key Macroindicators
Table 144 Mexico: Smart Pills Market, by Target Area, 2022-2030 (USD Million)
Table 145 Mexico: Smart Pills Market, by Application, 2022-2030 (USD Million)
Table 146 Mexico: Smart Pills Market, by Disease Indication, 2022-2030 (USD Million)
Table 147 Mexico: Smart Pills Market, by End-user, 2022-2030 (USD Million)
Table 148 Rest of Latin America: Smart Pills Market, by Target Area, 2022-2030 (USD Million)
Table 149 Rest of Latin America: Smart Pills Market, by Application, 2022-2030 (USD Million)
Table 150 Rest of Latin America: Smart Pills Market, by Disease Indication, 2022-2030 (USD Million)
Table 151 Rest of Latin America: Smart Pills Market, by End-user, 2022-2030 (USD Million)
Table 152 Middle East & Africa: Smart Pills Market, by Region, 2022-2030 (USD Million)
Table 153 Middle East & Africa: Smart Pills Market, by Target Area, 2022-2030 (USD Million)
Table 154 Middle East & Africa: Smart Pills Market, by Application, 2022-2030 (USD Million)
Table 155 Middle East & Africa: Smart Pills Market, by Disease Indication, 2022-2030 (USD Million)
Table 156 Middle East & Africa: Smart Pills Market, by End-user, 2022-2030 (USD Million)
Table 157 GCC Countries: Smart Pills Market, by Target Area, 2022-2030 (USD Million)
Table 158 GCC Countries: Smart Pills Market, by Application, 2022-2030 (USD Million)
Table 159 GCC Countries: Smart Pills Market, by Disease Indication, 2022-2030 (USD Million)
Table 160 GCC Countries: Smart Pills Market, by End-user, 2022-2030 (USD Million)
Table 161 Rest of Middle East & Africa: Smart Pills Market, by Target Area, 2022-2030 (USD Million)
Table 162 Rest of Middle East & Africa: Smart Pills Market, by Application, 2022-2030 (USD Million)
Table 163 Rest of Middle East & Africa: Smart Pills Market, by Disease Indication, 2022-2030 (USD Million)
Table 164 Rest of Middle East & Africa: Smart Pills Market, by End-user, 2022-2030 (USD Million)
Table 165 Overview of Strategies Deployed by Key Players in Smart Pills Market, January 2021-January 2025
Table 166 Smart Pills Market: Degree of Competition
Table 167 Smart Pills Market: Region Footprint
Table 168 Smart Pills Market: Application Footprint
Table 169 Smart Pills Market: Target Area Footprint
Table 170 Smart Pills Market: Disease Indication Footprint
Table 171 Smart Pills Market: End-user Footprint
Table 172 Smart Pills Market: Region Footprint
Table 173 Smart Pills Market: Detailed List of Key Startups/SME Players
Table 174 Smart Pills Market: Competitive Benchmarking of Key Startups/SME Players
Table 175 Smart Pills Market: Product Launches, Approvals, and Enhancements, January 2021-January 2025
Table 176 Smart Pills Market: Deals, January 2021-January 2025
Table 177 Smart Pills Market: Other Developments, January 2021-January 2025
Table 178 Medtronic: Company Overview
Table 179 Medtronic: Products/Services/Solutions Offered
Table 180 Medtronic: Product Approvals & Enhancements, January 2021-January 2025
Table 181 Medtronic: Deals, January 2021-January 2025
Table 182 Olympus Corporation: Company Overview
Table 183 Olympus Corporation: Products/Services/Solutions Offered
Table 184 Olympus Corporation: Other Developments, January 2021-January 2025
Table 185 Capsovision, Inc.: Company Overview
Table 186 Capsovision, Inc.: Products/Services/Solutions Offered
Table 187 Capsovision, Inc.: Product Approvals & Enhancements, January 2021-January 2025
Table 188 Intromedic: Company Overview
Table 189 Intromedic: Products/Services/Solutions Offered
Table 190 Jinshan Science & Technology: Company Overview
Table 191 Jinshan Science & Technology: Products/Services/Solutions Offered
Table 192 Anx Robotics: Company Overview
Table 193 Anx Robotics: Products/Services/Solutions Offered
Table 194 Anx Robotics: Product Launches, Approvals, and Enhancements, January 2021-January 2025
Table 195 Shenzhen Jifu Medical Technology Co. Ltd.: Company Overview
Table 196 Shenzhen Jifu Medical Technology Co. Ltd.: Products/Services/ Solutions Offered
Table 197 Etectrx: Company Overview
Table 198 Etectrx: Products/Services/Solutions Offered
Table 199 Etectrx: Product Enhancements, January 2021-January 2025
Table 200 Etectrx: Deals, January 2021-January 2025
Table 201 Bodycap: Company Overview
Table 202 Bodycap: Products/Services/Solutions Offered
Table 203 Bodycap: Product Launches, January 2021-January 2025
Table 204 Bodycap: Deals, January 2021-January 2025
Table 205 Check-Cap: Company Overview
Table 206 Check-Cap: Products/Services/Solutions Offered
Table 207 Check-Cap: Product Approvals, January 2021-January 2025
Table 208 Check-Cap: Expansions, January 2021-January 2025
Table 209 Shangxian Minimal Invasive Inc.: Company Overview
Table 210 Shangxian Minimal Invasive Inc.: Products/Services/Solutions Offered
Table 211 Veloce Corporation: Company Overview
Table 212 Biocam: Company Overview
Table 213 Endiatx: Company Overview
Table 214 Rf Co. Ltd.: Company Overview
Table 215 Celero Systems: Company Overview
Table 216 Biora Therapeutics, Inc.: Company Overview
Table 217 Innurvation: Company Overview
Table 218 Rani Therapeutics: Company Overview
Table 219 Motilis Medica SA: Company Overview

Figure 1 Smart Pills Market Segmentation & Geographical Spread
Figure 2 Smart Pills Market: Years Considered
Figure 3 Smart Pills Market: Research Design
Figure 4 Smart Pills Market: Key Data from Secondary Sources
Figure 5 Smart Pills Market: Key Primary Sources
Figure 6 Smart Pills Market: Key Data from Primary Sources
Figure 7 Smart Pills Market: Insights from Key Primaries
Figure 8 Breakdown of Primary Experts: by Company Type, Designation, and Region
Figure 9 Market Size Estimation: Supply-Side Analysis
Figure 10 Smart Pills Market: Bottom-Up Approach (Demand-Side Analysis)
Figure 11 Smart Pills Market: Top-Down Approach
Figure 12 Smart Pills Market: CAGR Projections from Analysis of Drivers, Restraints, Opportunities, and Challenges (2024-2030)
Figure 13 Smart Pills Market: CAGR Projections (Supply Side)
Figure 14 Smart Pills Market: Data Triangulation
Figure 15 Smart Pills Market, by Application, 2024 vs. 2030 (USD Million)
Figure 16 Smart Pills Market, by Target Area, 2024 vs. 2030 (USD Million)
Figure 17 Smart Pills Market, by Disease Indication, 2024 vs. 2030 (USD Million)
Figure 18 Smart Pills Market, by End-user, 2024 vs. 2030 (USD Million)
Figure 19 Regional Snapshot of Smart Pills Market
Figure 20 Increasing Adoption of Capsule Endoscopy in Emerging Economies to Fuel Uptake of Smart Pills
Figure 21 US and Capsule Endoscopy Segments Dominated North American Smart Pills Market in 2023
Figure 22 China to Register Highest Growth Rate from 2024 to 2030
Figure 23 Asia-Pacific to Grow at Highest CAGR During Forecast Period
Figure 24 Emerging Markets to Register Highest Growth Rate During Study Period
Figure 25 Smart Pills Market: Drivers, Restraints, Opportunities, and Challenges
Figure 26 Healthcare Security Breaches of 500 + Records, 2009-2024
Figure 27 Smart Pills Market: Trends/Disruptions Impacting Customer's Business
Figure 28 Smart Pills Market: Porter's Five Forces Analysis
Figure 29 Influence of Key Stakeholders on Buying Process, by Application
Figure 30 Key Buying Criteria for Smart Pills, by Application
Figure 31 Smart Pills Market: Ecosystem Analysis
Figure 32 Smart Pills Market: Value Chain Analysis
Figure 33 Average Selling Price of Smart Pills, by Key Player (2023)
Figure 34 Smart Pills Market: Global Patent Publication Trends (2015-2024)
Figure 35 Top Applicants (Companies/Institutions) for Smart Pill Patents (January 2014-December 2024)
Figure 36 Top Applicants for Smart Pill Patents (Country/Region) (January 2014-December 2024)
Figure 37 Smart Pills Market: Funding and Number of Deals (2020-2024)
Figure 38 Market Potential of AI/Gen AI on Smart Pills Across Industries
Figure 39 Impact of AI/Gen AI on Interconnected and Adjacent Ecosystems
Figure 40 North America: Smart Pills Market Snapshot
Figure 41 Asia-Pacific: Smart Pills Market Snapshot
Figure 42 Revenue Analysis of Key Players in Smart Pills Market, 2019-2023 (USD Million)
Figure 43 Market Share Analysis of Key Players in Smart Pills Market (2023)
Figure 44 Smart Pills Market: Company Evaluation Matrix (Key Players), 2023
Figure 45 Smart Pills Market: Company Footprint
Figure 46 Smart Pills Market: Company Evaluation Matrix (Startups/SMEs), 2023
Figure 47 EV/EBITDA of Key Vendors
Figure 48 Year-To-Date (Ytd) Price Total Return and 5-Year Stock Beta of Key Vendors
Figure 49 Smart Pills Market: Brand/Product Comparative Analysis
Figure 50 Medtronic: Company Snapshot
Figure 51 Olympus Corporation: Company Snapshot